Literature DB >> 23815299

Effect of four different size reduction methods on the particle size, solubility enhancement and physical stability of nicergoline nanocrystals.

Valentina Martena1, Ranjita Shegokar, Piera Di Martino, Rainer H Müller.   

Abstract

Nicergoline, a poorly soluble active pharmaceutical ingredient, possesses vaso-active properties which causes peripheral and central vasodilatation. In this study, nanocrystals of nicergoline were prepared in an aqueous solution of polysorbate 80 (nanosuspension) by using four different laboratory scale size reduction techniques: high pressure homogenization (HPH), bead milling (BM) and combination techniques (high pressure homogenization followed by bead milling HPH + BM, and bead milling followed by high pressure homogenization BM + HPH). Nanocrystals were investigated regarding to their mean particles size, zeta potential and particle dissolution. A short term physical stability study on nanocrystals stored at three different temperatures (4, 20 and 40 °C) was performed to evaluate the tendency to change in particle size, aggregation and zeta potential. The size reduction technique and the process parameters like milling time, number of homogenization cycles and pressure greatly affected the size of nanocrystals. Among the techniques used, the combination techniques showed superior and consistent particle size reduction compared to the other two methods, HPH + BM and BM + HPH giving nanocrystals of a mean particle size of 260 and 353 nm, respectively. The particle dissolution was increased for any nanocrystals samples, but it was particularly increased by HPH and combination techniques. Independently to the production method, nicergoline nanocrystals showed slight increase in particle size over the time, but remained below 500 nm at 20 °C and refrigeration conditions.

Entities:  

Keywords:  Dissolution; mean particle size; nanocrystals; nicergoline; short term stability

Mesh:

Substances:

Year:  2013        PMID: 23815299     DOI: 10.3109/03639045.2013.810635

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  2 in total

1.  In vivo treatment of experimental neurocysticercosis with praziquantel nanosuspensions-a metabolic approach.

Authors:  Luciana Damacena Silva; Nayana Ferreira Lima; Eva Carolina Arrua; Claudio Javier Salomon; Marina Clare Vinaud
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

2.  Role of nicergoline in corneal wound healing in diabetic rats.

Authors:  Amanda Lemos Barros Martins Portela; Rafael Neves Moreno; Maria Helena Madruga Lima Ribeiro; Fernanda Miguel de Andrade; Yale Viana Alves; Mônica Alves; Rodrigo Pessoa Cavalcanti Lira
Journal:  BMC Ophthalmol       Date:  2021-02-09       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.